- Home
- RCKT vs TKNO Comparison
RCKT vs TKNO Comparison
Compare RCKT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- TKNO
- Stock Information
- Founded
- RCKT 1999
- TKNO 1996
- Country
- RCKT United States
- TKNO United States
- Employees
- RCKT N/A
- TKNO N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- RCKT Health Care
- TKNO Health Care
- Exchange
- RCKT Nasdaq
- TKNO Nasdaq
- Market Cap
- RCKT 328.6M
- TKNO 356.4M
- IPO Year
- RCKT N/A
- TKNO 2021
- Fundamental
- Price
- RCKT $3.14
- TKNO $5.18
- Analyst Decision
- RCKT Buy
- TKNO
- Analyst Count
- RCKT 13
- TKNO 0
- Target Price
- RCKT $14.79
- TKNO N/A
- AVG Volume (30 Days)
- RCKT 3.6M
- TKNO 387.8K
- Earning Date
- RCKT 08-08-2025
- TKNO 08-07-2025
- Dividend Yield
- RCKT N/A
- TKNO N/A
- EPS Growth
- RCKT N/A
- TKNO N/A
- EPS
- RCKT N/A
- TKNO N/A
- Revenue
- RCKT N/A
- TKNO $38,250,000.00
- Revenue This Year
- RCKT N/A
- TKNO $8.73
- Revenue Next Year
- RCKT $608.87
- TKNO $16.53
- P/E Ratio
- RCKT N/A
- TKNO N/A
- Revenue Growth
- RCKT N/A
- TKNO 3.79
- 52 Week Low
- RCKT $2.19
- TKNO $3.16
- 52 Week High
- RCKT $26.98
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- RCKT 49.02
- TKNO 54.38
- Support Level
- RCKT $3.03
- TKNO $4.04
- Resistance Level
- RCKT $3.54
- TKNO $5.31
- Average True Range (ATR)
- RCKT 0.21
- TKNO 0.33
- MACD
- RCKT 0.09
- TKNO 0.10
- Stochastic Oscillator
- RCKT 49.37
- TKNO 85.07
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.